Compare CLRB & RBNE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CLRB | RBNE |
|---|---|---|
| Founded | 2002 | 2024 |
| Country | United States | Cyprus |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Marine Transportation |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.9M | 11.5M |
| IPO Year | N/A | N/A |
| Metric | CLRB | RBNE |
|---|---|---|
| Price | $3.32 | $3.64 |
| Analyst Decision | Hold | |
| Analyst Count | 1 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 34.5K | ★ 302.3K |
| Earning Date | 03-12-2026 | 04-17-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.09 |
| Revenue | N/A | ★ $6,869,234.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $45.39 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.45 | $2.78 |
| 52 Week High | $20.60 | $123.25 |
| Indicator | CLRB | RBNE |
|---|---|---|
| Relative Strength Index (RSI) | 47.29 | 49.44 |
| Support Level | $3.14 | $3.67 |
| Resistance Level | $3.42 | $4.20 |
| Average True Range (ATR) | 0.21 | 0.56 |
| MACD | -0.00 | -0.12 |
| Stochastic Oscillator | 56.06 | 16.25 |
Cellectar Biosciences Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of drugs for the treatment of cancer. The company's core objective is to leverage a proprietary phospholipid drug conjugate (PDC) delivery platform to develop PDCs that are designed to specifically target cancer cells and deliver improved efficacy and safety as a result of fewer off-target effects. It has one operating and reportable segment focused on utilizing its PDC platform to develop drugs for the treatment of cancer.
Robin Energy Ltd operates a tanker vessel that engages in the transportation of refined petroleum products using its Handysize product tanker.